Borgå O, Borgå B
Office of Clinical Pharmacology and Biopharmaceutics, Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, Maryland 20857, USA.
J Pharmacokinet Biopharm. 1997 Feb;25(1):63-77. doi: 10.1023/a:1025719827072.
The unbound fraction in serum, fu, is a critical parameter in describing and understanding the pharmacokinetics of NSAIDs. We compared fu for 6 different NSAIDs using ultrafiltration of pooled serum at pH 7.4 and 24C. Measurements covered a wide concentration range in order to define binding affinity and number of binding sites. HPLC was used to measure drug concentrations in serum and ultrafiltrate. Direct injection of ultrafiltrate and serum (diluted 250 x) permitted quantitation down to approximately 70 nM for most of the NSAIDs, i.e., approximately 15-20 ng/ml. Assuming binding only to albumin, the data were fitted to a model of two classes of binding sites with dissociation constants K1 and K2. The lowest K1 (highest affinity) was found with flurbiprofen, 0.0658 microM, the highest with ketoprofen, 5.23 microM, an 80-fold difference. At low drug concentrations, fu becomes virtually constant and approaches a lower limit, fumin. The following fumin values were calculated: diclofenac 0.21%; fenoprofen 0.25%, flurbiprofen 0.022%, ketoprofen 0.52%, naproxen 0.039%, and tolmetin 0.37%. Thus the least bound NSAID, ketoprofen, had a value 24-fold that of the most highly bound, flurbiprofen. The NSAIDs also differed widely with regard to the extent of variation in fu within the range of therapeutic concentrations, and hence with regard to their potential as displacers of other drugs.
血清中的游离分数fu是描述和理解非甾体抗炎药(NSAIDs)药代动力学的关键参数。我们在pH 7.4和24℃条件下,通过对混合血清进行超滤,比较了6种不同NSAIDs的fu。测量涵盖了较宽的浓度范围,以确定结合亲和力和结合位点数量。采用高效液相色谱法(HPLC)测量血清和超滤液中的药物浓度。直接进样超滤液和血清(稀释250倍)可对大多数NSAIDs进行低至约70 nM的定量分析,即约15 - 20 ng/ml。假设仅与白蛋白结合,将数据拟合到具有解离常数K1和K2的两类结合位点模型。发现氟比洛芬的K1最低(亲和力最高),为0.0658 μM,酮洛芬的K1最高,为5.23 μM,相差80倍。在低药物浓度下,fu实际上变得恒定并接近下限fumin。计算得到以下fumin值:双氯芬酸0.21%;非诺洛芬0.25%,氟比洛芬0.022%,酮洛芬0.52%,萘普生0.039%,托美丁0.37%。因此,结合最少的NSAIDs(酮洛芬)的值是结合最多的(氟比洛芬)的24倍。NSAIDs在治疗浓度范围内fu的变化程度也有很大差异,因此在作为其他药物置换剂的潜力方面也存在差异。